US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Completed

Sterile Diluent

Reason CGMP Deviations

Eli Lilly & Company D-0445-2024
Class II · Moderate risk Ongoing

Infumorph

Reason The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Hikma Pharmaceuticals USA Inc. NDC 0641-6039-01 D-0392-2024
Class II · Moderate risk Terminated

Tri-Lo-Sprintec

Reason Failed Dissolution Specifications

Teva Pharmaceuticals USA, Inc NDC 0093-2140-62 D-0428-2024
Class II · Moderate risk Terminated

Potassium Chloride for Injection Concentrate USP

Reason Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.

B. Braun Medical Inc NDC 0264-1944-20 D-0370-2024
Class II · Moderate risk Terminated

Betimol

Reason Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.

Thea Pharma, Inc. NDC 82584-002-15 D-0374-2024
Class I · High risk Ongoing

Treprostinil Injection

Reason Presence of Particulate Matter.

Par Sterile Products LLC D-0429-2024
Class III · Low risk Terminated

Digoxin Tablets

Reason Cross Contamination with Other Products:(mycophenolate mofetil).

Novitium Pharma LLC NDC 70954-201-20 D-0389-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 80mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-060-01 D-0369-2024
Class II · Moderate risk Ongoing

Febuxostat Tablets 40mg

Reason CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.

Sun Pharmaceutical Industries INC NDC 16714-059-01 D-0368-2024
Class II · Moderate risk Completed

S.P Labs

Reason Failed Stability Specifications

Specialty Process Labs LLC D-0447-2024
Class II · Moderate risk Completed

S.P.Labs

Reason Failed Stability Specifications

Specialty Process Labs LLC NDC 81305-500-01 D-0446-2024
Class II · Moderate risk Ongoing

FentaNYL citrate

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0436-2024
Class II · Moderate risk Ongoing

Phenylephrine HCl

Reason Lack of Assurance of Sterility: Firm did not perform process validation.

SSM Health Care St. Louis DBA SSM St. Clare Health Center D-0435-2024
Class II · Moderate risk Ongoing

hyalogic For Dry Eyes

Reason Lack of Assurance of Sterility

Optikem International, Inc. D-0384-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Red Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-158-15 D-0383-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Pink Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-013-15 D-0382-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Aging Eye Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-027-15 D-0381-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Floaters Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-098-15 D-0380-2024
Class II · Moderate risk Ongoing

TRP Eye strain Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-172-15 D-0379-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Dryness Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-178-15 D-0378-2024
Class II · Moderate risk Ongoing

TRP Eye Twitching Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-040-15 D-0377-2024
Class II · Moderate risk Ongoing

TRP Blur Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-002-11 D-0376-2024
Class II · Moderate risk Ongoing

TRP Natural Eyes Allergy Eyes Relief

Reason Lack of Assurance of Sterility

Optikem International, Inc. NDC 17312-032-15 D-0375-2024
Class II · Moderate risk Terminated

Tobramycin for Injection

Reason Failed Stability Specification: Water determination was found not complying with specification.

Eugia US LLC NDC 55150-470-06 D-0385-2024
Class II · Moderate risk Ongoing

Nicardipine Hydrochloride Injection

Reason Failed Impurities/Degradation Specifications: Out of specification for organic impurities

Eugia US LLC NDC 55150-183-11 D-0391-2024